Prelude Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Prelude Therapeutics

Access the complete profile.

Prelude Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	200 Powder Mill Rd Wilmington, DE 19803

Note: Revenues for privately held companies are statistical evaluations.


Prelude Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Prelude Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Prelude Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Prelude Therapeutics Annual Revenue and Growth Rate

Prelude Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Prelude Therapeutics's revenues are gauged from an analysis of company filings.

Prelude Therapeutics's Income Statement (based on Industry Averages)

Prelude Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Prelude Therapeutics is developing and marketing. Prelude Therapeutics doesn't have any recent trademark applications, indicating Prelude Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark

Date

PRELUDE THERAPEUTICS Research and development of drugs in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research for medical purposes in the fields of oncology, hematology, autoimmune diseases, and rare diseases; clinical research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research and development of pharmaceuticals and biopharmaceuticals for the treatment of cancer, hematological diseases, autoimmune diseases, and rare diseases; providing websites featuring medical and scientific research information about pharmaceutical and biopharmaceutical drugs and their preparations; genetic testing for scientific research; genetic research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; none of the foregoing in relation to or in the field of fertility services

05/31/2019

See all trademarks and details in the Full Report.

Market Share of Prelude Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Prelude Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Prelude Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
INCYTE	Wilmington, DE	100
INTERDIGITAL COMMUNICATIONS	Wilmington, DE	12
PRELUDE THERAPEUTICS	Wilmington, DE	8
BIOSPECIFICS TECHNOLOGIES	Wilmington, DE	6
NIKANG THERAPEUTICS	Wilmington, DE	3
CLOVER BIOPHARMACEUTICALS USA IN	Wilmington, DE	2

Other Companies at 200 Powder Mill Rd, Wilmington DE

Company	Headquarters	Revenue ($ MM)
DUPONT SPECIALTY PRODUCTS USA	Wilmington, DE	100
NAPIGEN	Wilmington, DE	0
INVENTIA SCIENTIFIC	Wilmington, DE	0
APOLLODYNE	Wilmington, DE	0
LISEN IMPRINTING DIAGNOSTICS	Wilmington, DE	0

Future Competition: Prelude Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Prelude Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)